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The contribution of leukocytes, macrophages, or other phagocytic cell ele- 
ments of the reticuloendothefial system to host defense in viral infections has 
never been fully defined. Viruses have been found associated with,  and  iso~ 
lated from, peripheral white blood cells during infection (1-9). Other workers 
have noted either the failure of leukocytes or macrophages to exert a  clearly 
defined viricidal effect or have demonstrated virus  replication in  these  cells 
(5, 9--21).  On  the basis  of these data it has been postulated  that leukocytes 
may actually contribute to the dissemination of viruses in the host  (5, 9-13, 
22). 
Contrasting evidence, on the other hand, has been presented in a number of 
studies which have failed to demonstrate viral replication in phagocytic cells 
(16,  22-25)  or have correlated host resistance with resistance to viral multi- 
plication  of macrophages  or  reticuloendothefial system both  in  ~/vo and  in 
vitro (26-29). 
Recent reports of interferon production in human leukocytes by Gresser (30) 
and  in  mouse  macrophages  by  Glasgow  and  Habel  (31)  suggest  a  possible 
mechanism by which these cells may contribute to host defenses in the absence 
of a direct viricidal action. 
The present studies were initiated to develop a  model to study the role of 
leukocytes in the host response to viral infections by using an in ~itro system 
which  eliminates  the  host  jmmtme  mechanisms.  It  was  hoped  that  such  a 
model would allow us  to examine the two components of the leukocytic re- 
sponse, namely, interferon production and phagocytosis. 
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825), United States Public Health Service.  This investigation  was partially supported by an 
American Cancer Society Research Grant No. IN-18-F and by the Public Health Service 
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Materials and Methods 
Virus.--A calf lymph strain of vaecinia virus maintained by passage in monkey kidney cul- 
tures was originally obtained from Dr. Joel Warren. The virus pool was prepared in HeLa cell 
cultures and titered 8 X 106 plaque-forming units (PFU) per ml. 
Vesicular stomatitis virus (VSV), Indiana  strain, was obtained from the American  Type Cul- 
ture Collection, Rockville, Maryland.  Virus pools were grown in primary mouse embryo 
fibroblast cultures (MEF) and titered 4 X 106 PFU per mi on assay in ME-29 cells (31). 
Encephalomyocarditis virus (EMC) was a large plaque-forming mutant, EMC r, obtained 
from Dr. K. K. Takemoto, National Institutes of Health. Virus pools were prepared in L cells 
and titered approximately 8 X 106 PFU per 0.2 ml in primary MEF. 
Cells.--Primary  mouse embryo (MEF)  cells used in these experiments were prepared by 
trypsinization of 13- to 16-day-old  embryos from random bred mice obtained from the Western 
New York Animal Resources, Webster, New York (strain MLM-1 derived from a ICR strain). 
Leukocytes  were obtained  from  30  to  45  gm  ex-breeder CD-I  mice obtained  from 
the Charles River Mouse Farms, Wilmington, Massachusetts. Animals were inoculated intra- 
peritoneally with 2 mi of nutrient broth. White cell preparations containing 1 to 2 X 10  e cells 
per mi were obtained  18 to 24 hours later by flushing the peritoneal cavity with 10 mi of 
Eagle's medium. Differential counts of the peritoneal exudate showed 8 to 30 per cent poly- 
morphonuciear and 70 to 92 per cent mononuclear cells. 
ME-29 is an established mouse embryo fibroblast tissue culture line which has been de- 
scribed previously (31). 
Med/a.--All tissue cells were maintained in Eagle's MEM medium with 5 to 10 per cent 
calf serum (Hyland Laboratories, Los Angeles, California). The media used for plaque titra- 
tions was Eagle's MEM with Difco noble agar and 5 per cent calf serum. 
Virus Titration.--Vacdmi~  virus was assayed by a plaque method in HeLa cells. Virus sam- 
pies were serially diluted, adsorbed for 3 hours, and overlaid with 5 ml of agar medium. A sec- 
ond overlay containing a final concentration of 1: 20,000 neutral red was made on the 4th day 
and plaques were counted on the 5th, 6th, and 7th days. 
Interferon Assay.--Interferon preparations were cleared of cellular debris by centrifugation, 
acid-treated for 20 to 24 hours to destroy infectious particles as previously described (24), and 
assayed by the plaque reduction technique in ME-29 or primary MEF cultures utilizing VSV 
or EMC r as the challenge virus. 
Interferon preparations were characterized by: (a) failure to inhibit plaque formation by 
Sindbis or vaccinia virus in chick embryo cultures; (b) trypsin sensitivity; (c) stability at 56°C 
for 30 minutes; and (d) failure to be sedimented at 100,000 g for 1 hour. 
RESULTS 
Primary mouse embryo fibroblast cultures (MEF) are susceptible to vaccinia 
virus infection following initiation of infection with a  low inoculum, 50 to 200 
PFU.  Circumscribed plaque-like foci  of  cell  destruction develop  which  are 
visible in the gross and may be counted. The MEF cultures were less suscep- 
tible than HeLa ceils to vaccinia virus infection as evidenced by the reduced 
plaquing efficiency; 50 to  200 PFU (HeLa)  initiated only 5  to 40 plaques in 
MEF. Progression of the infection is manifested by the increase in size of these 
foci  of  cytopathic  effect  (CPE),  presumably by cell  to  cell  transmission of 
virus, and by the development of new foci or plaques by the spread of virus 
through  the  culture medium. This vaccinia virus-MEF system provided an LOWELL  A.  GLASGOW  1003 
excellent model for this study because: (a) the progression of the infection was 
slow, requiring 5  to  14 days for complete destruction of the culture;  (b)  in 
previously reported studies we demonstrated interferon production in mouse 
embryo tissue (31) and mouse leukocytes (24), and presented data suggesting 
that interferon production was a  significant factor in the resistance of a  con- 
tinuous  line  of mouse  embryo fibroblasts  (3-B)  to  vaccinia  virus  infection; 
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TExT-FzG. 1. Protective effect of leukocytes  on a vaccinia virus infection  in prin~ry MEF 
cultures, experiment  2-A. Progression  of the infection  is plotted as the number of plaque-like 
loci per bottle. Each point represents  the average  of two bottles. 
and finally (c)  the course of infection could be quantitated both by counting 
the gross plaques and by assaying the supernatant fluid for virus. 
Protective Effect of Leukocyte,  s.--Repglcate cultures of primary MEF in  12- 
ounce prescription bottles were infected with 50 to 200 PFU of vaccinia virus 
in 0.5 ml of Eagle's MEM. Mter 1~,~ hours' adsorption, 1 to 2 ml of the mouse 
leukocyte preparation containing 1~,~ to 3  )<  10  e leukocytes was added to the 
culture and then the volume of medium was brought up to 15 ml by the addi- 1004  LEUKOCYTES  AND  INTERFERON.  I 
tion  of Eagle's MEM.  The progression of the  infection was quantitated  by 
daily  counts  of the  plaque-like  loci  of infection  visible in  the  gross  and by 
harvesting samples for virus assay. 
Data from 1 experiment using an inoculum of 200 PFU are summarized in 
Text-fig.  1.  Each  point represents the  average daily plaque  count  from two 
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TExT-FIG. 2. The effect of leukocytes in suppressing the progression of vaccinia virus in- 
fection in primary MEF cultures. Vaccinia  virus titers in supernatant fluids of control cultures 
and cultures to which leukocytes  have been added are expressed  as PFU per ml. 
cultures  handled  in an identical  fashion.  All  cultures had  approximately the 
same number of plaques by day 1, which indicated  that most of the inoculum 
had adsorbed to susceptible cells prior to the addition of leukocytes and that 
the leukocytes affected only the progress of the infection after cell penetration. 
The results  of this  experiment demonstrate  that  addition  of leukocytes pro- 
duced a significant suppression of viral proliferation and also of spread of CPE 
as  evidenced by  inhibition  of  the  development  of new  foci  of infection.  In 
addition  slower enlargement of the  existing plaques  occurred in  the  cultures 
treated with leukocytes. This protective effect was observed in cultures where LOWELL  A.  GLASGOW  1005 
a peritoneal-leukocyte mixture was used or where the leukocytes were washed 
prior to their addition to the cultures. The effect of leukocytes on the progress 
of virus  infection was  confirmed by virus  assays  on  aliquots  of the  culture 
medium sampled periodically during the course of the experiment, Text-fig. 2. 
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TExT-FIG. 3.  Control of vaccinia virus infection in primary MEF by addition of peritonea 
leukocytes. Progression of infection in control cultures (©  O)  ([-]  [~) is compared 
with replicate cultures to which leukocytes have been added. Progression of the infection is 
quantitated by gross plaque counts. Each point represents the average of three bottles. 
Fluids  harvested  from  the  leukocyte-MEM  group  contained  only  approxi- 
mately 2 per cent as much virus as was found in similar samples from control 
cultures. 
Other  replicate  sets  of  cultures  received  an  equal  volume  of  peritoneal 
exudate  with  leukocytes  removed  by  centrifugation  to  control  for  possible 
virus  inhibitors  present  in  the  peritoneal  fluid.  In  4  of the  30  experiments 
which  comprised these studies  a  moderate degree of inhibition was exhibited 
by peritoneal fluid controls. In no instance  was this  of the magnitude  of the 
protective effect of the leukocytes. 1006  LEUKOCYTES AND INTERFERON. I 
Another  set  of  replicate  cultures  received  an  equal  volume  of peritoneal 
exudate in which the leukocytes were killed by heating at 56°C for 10 minutes. 
The failure to  observe protection  suggested that  the protective effect was a 
function  of living cells. 
During  the  course of the  30  experiments on which  this report is based,  a 
variation was noted in the protective effect of the leukocytes. The experiment 
presented  in Text-fig.  1 represented one in which  a  low degree of protection 
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TEXT-FIG.  4.  In vitro  recovery from vaccinia virus infection in primary MEF cultures, 
following addition of peritoneal leukocytes. Vaccinia virus titers of supematant fluids from 
control cultures and cultures to which leukocytes were added are expressed as PFU per ml. 
was observed. In Text-fig. 3  the results of an experiment in which a  striking 
protective effect was noted are summarized. The protocol differs in two ways 
from that  illustrated  in Text-fig.  1;  the  initial  viral inoculum contained  ap- 
proximately 40 to 50 PFU as opposed to 200  PFU and a  second addition  of 
leukocytes was made on the 4th day. It was noted during these studies  that 
the  leukocytes  provided  a  greater  degree  of  protection  when  the  inoculum 
was  low  and  that  with  increasing  multiplicity  of  infection,  the  leukocytes' 
defense  could  be  overcome.  In  this  experiment  the  vaccinia  virus  infection 
was controlled and after 5 to 7 days, regrowth of cells into the areas of CPE 
occurred.  Over  the  subsequent  2-week period,  the  plaques  gradually  disap- 
peared  and  were  reolaced  bv a  normal  healthy  monolayer of cells.  Samples LOWELL  A.  GLASGOW  1007 
taken of the culture fluid during the course of this experiment were assayed 
for virus and the results are presented in Text-fig. 4. Vaccinia virus was cleared 
from the leukocyte-MEF culture; an in vitro recovery had occurred. 
A series of photomicrographs (Figs. 1 to 3) illustrate the progression of CPE 
from a single focus of infection to wide-spread destruction in a control culture. 
These may be compared with the recovery process illustrated in a  leukocyte- 
MEF culture (Figs. 4 to 6). 
Production  of Interferon.--The  effect of leukocytes which  was  observed is 
explicable in terms of at least two possible mechanisms: (a) a mechanical effect 
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~T-FIG. 5. Interferon activity, expressed as per cent plaque reduction, in supernatant 
fluids of vacciuia virus infected primary MEF cultures. Higher levels  of interferon are demon- 
strated in cultures to which leukocytes  were added in comparison  with replicate control cul- 
tures to which lenkocytes  were not added. 
of phagocytosis with  inability  of phagocytosed particles  to replicate within 
the leukocytes; or (b) interferon production by leukocytes which had phago- 
cytosed or become infected with vaccinia virus. We have previously reported 
interferon production by vaccinia virus-infected mouse leukocytes (24) and it 
seemed probable that interferon production was a factor in the results described 
above. 
Samples  of  medium  from  control  and  leukocyte-MEF  cultures  from  1 
experiment were harvested, cleared of cell debris by centrifugation, and acid- 
treated as described in Materials and Methods. Serial dilutions of the resultant 
preparations were assayed for interferon activity in ME-29 or primary MEF 
cultures by the plaque reduction technique. 
The interferon assays  from  this  experiment  are  presented  in  Text-fig. 5. 
Interferon was demonstrated in both control and leukocyte-cultures, however, 
a significantly greater titer was present in the culture to which leukocytes were 1008  LEUKOCYTES  AND  INTERFERON.  I 
added.  Interferon production by vaccinia virus-mouse tissue systems is rela. 
tively low. The data presented in Text-fig. 5 are from an experiment in which 
a relatively high inoculum of vaccinia virus was used and in which a moderate 
degree  of  CPE  was present  in  both  groups  of cultures.  In fluids  harvested 
from experiments in which a low virus inoculum was utilized, interferon could 
be demonstrated only with undiluted fluids or not at all, and significant differ; 
ences in interferon production between the groups were not obtainable. These 
low interferon titers would be expected since probably 98 per cent or more of 
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TExT-FIo. 6. Lack of protective effect of mouse peritoneal leukocytes in vacciuia virus-in- 
fected chick embryo tissue. Vaccinia virus titers in supernatant fluids from control MEF and 
leukocyte-MEF cultures, assayed in HeLa cells, are plotted as PFU per ml. 
the  total  cell  population  in  cultures  infected  with  a  low  inoculum  remain 
uninfected by vaccinia virus and hence are able to absorb the interferon pro- 
duced by the small number of infected interferon-producing cells. 
Species  Specificity  of Leukocyte  Protection.--Further  experiments  were  de- 
signed  to  delineate  the  relative  contribution  of phagocytosis  and  interferon 
production to the observed protective effect. The species specificity of mouse 
interferon  has  recently  been  definitively  established  with  highly  purified 
preparations  (32);  mouse interferon has  no protective effect in chick  tissue. 
Identical experiments were carried out, therefore, with vaccinia virus infections LOW'ELL  A.  GLASGOW  1009 
in chick embryo tissue.  The course of viral infection in control cultures was 
compared with that in cultures to which mouse leukocytes were added.  The 
loci of infection were  considerably less  distinct  in  chick embryo tissue  and 
gross plaque counts were not possible. CPE, however, appeared to progress at 
similar rates in both control and mouse leukocyte-chick embryo cultures with 
eventual destruction of all cultures. The results of virus assays on culture fluid 
samples from a representative experiment (Text-fig. 6) confirm the impression 
that  viral infection was  not  affected by  the  addition  of mouse  leukocytes. 
Virus titers in all fluids rose in a  logarithmic fashion until cultures were de- 
stroyed. There was no demonstrable protective effect of mouse leukocytes in 
chick embryo cell cultures. 
These data have  been interpreted to indicate  that  phagocytosis of extra- 
TABLE I 
Failure of Mouse Leukocytes to Inhibit  Vaccinia Virus Plaque Formation in 
Chick Embryo Tissue 
Experimental group 
Virus alone  ............................ 
Virus +  leukocytes  at time 0* ........... 
Virus +  leukocytes  at I hr.* ........... 
Virus +  leukocytes  at 2 hrs.* ........... 
Virus +  leukocytes  at 3 hrs.* ........... 
Exp.  I 
78 
69 
70 
68 
66 
No. of plaques 
Exp. 2 
30 
34 
36 
32 
Exp. 3 
52 
53 
61 
62 
* Virus inoculum was added to all groups at time 0 and leukocytes at the time intervals 
indicated. 
cellular viral particles plays a relatively minor role in the suppression of viral 
spread and proliferation and suggest that interferon is the significant factor in 
the  observed suppressive  effect  of leukocytes on vaccinia virus  infection in 
~tro. 
To further define the relative roles of phagocytosis and interferon production 
in the observed protective e~ect, a series of experiments was designed to utilize 
further the  species  specificity of interferon to diaerentiate  these  two mecha- 
nisms. In preliminary  experiments it was demonstrated that addition of mouse 
leukocytes simultaneously with  the  vaccinia virus inoculum to mouse  tissue 
cultures decreased the number of loci of infection which were initiated.  It was 
postulated that phagocytosis of virus particles by leukocytes might be respon- 
sible for this inhibitory effect on primary plaque formation. If this hypothesis 
were  true  then primary,  but  not  secondary, plaque  formation should be  in- 
hibited in heterologous tissue. Data from a series of experiments in chick embryo 
cultures are summarized in Table I. Cultures of chick-embryo fibroblasts were 1010  LEUKOCYTES  AND  INTERFERON.  I 
inoculated with 0.5  ml  of vaccinia virus  containing  approximately 50  PFU. 
One set of 5 plates received 0.5 ml of MEM containing 6  ×  105 to 106 mouse 
peritoneal  leukocytes simultaneously with  the  virus  inoculmn  while  similar 
leukocyte preparations were added to other groups at  1, 2, and 3 hour inter- 
vals. The dilution effect of the addition of 0.5 ml of medium was controlled 
by adding 0.5 ml of MEM  to two additional control plates at each time in- 
terval. This volume increase had no effect on plaquing efficiency and so these 
controls have not been included in the summary of results in Tables I  and II. 
Liquid media  containing  the  added  leukocytes was  removed after  12  to  18 
hours and plates  were overlaid with  agar-plaque media, plates were stained 
TABLE II 
Inhibition of Vaccinia Plaque Formation in HeLa Call Cultures By Addition of Mouse Leukocytes 
Experimental group 
Virus alone ......................... 
Virus +  leukocytes  at time O* ........ 
Virus +  leukocytes  at 2 hrs.* ......... 
Virus +  leukocytes  at 3 hrs.* ......... 
Exp. 1 
41 
27 
45 
No. of plaques 
Exp. 2 
200 
32 
91 
125 
* Virus inoculum was added to all groups at time 0  and leukocytes at the time intervals 
indicated. 
with neutral red and plaques counted on the 3rd and 4th days. Since the ma- 
jority of the vaccinia virus inoculum should be attached to cells by 3 hours, it 
was thought that phagocytosis of virus particles, if it occurred, would be mani- 
fested primarily in plates to which leukocytes were added at time 0  or at  1 
hour. The failure to detect any reduction in primary plaque formation, there- 
fore, was  unexpected. The data presented represents  3  of 5  experiments in 
which the results were reproduced. The results suggest that under the condi- 
tions  of these  experiments, mouse leukocytes failed to  compete successfully 
for virus particles with the monolayer of chick fibroblasts and that phagocyto- 
sis of vaccinia virus by leukocytes was not a  significant factor in preventing 
the initiation of infection. 
To extend these studies an identical protocol, with the exception of the sub- 
stitution of HeLa cells  for chick embryo fibroblasts, was utilized  in  the  fol- 
lowing series of experiments.  Again,  an  unexpected result  was  obtained.  In 
contrast to the lack of inhibitory effect in chick tissue, mouse leukocytes signif- 
icantly reduced the formation of primary plaques in human ceils. In a  previous 
paper (31) we had noted that in contrast to the species specificity in mouse- 
chicken system, a  low degree of antiviral  activity by mouse interferon was 
demonstrable in HeLa cells. LOWELL  A.  GLASGOW  1011 
In  order  to  determine  whether interferon produced by mouse leukocytes 
could be effective in human tissue under our present experimental conditions 
and could explain the plaque inhibition in HeLa cells, assays of mouse derived 
interferon were compared in cell cultures derived from the three species. Results 
are summarized in Table III. Interferon of mouse origin was again shown to 
exert a  significant, though reduced, inhibitory effect in HeLa cultures. It is 
thought,  therefore,  that  these  data are  consistent with the hypothesis that 
leukocyte-produced interferon was the primary factor in the in ~itro control 
of vaccinia virus infection. 
Interferon Elimination By  Trypsin.--In  order to define further the role of 
interferon in this in vitro model we attempted to alter a single variable by elimi- 
TABLE  HI 
The antivlral effect of interferon produced in cultures of mouse fibroblast is compared in 
mouse, HeLa and chick cells using a  vaccinia virus plaque inhibition assay.  Interferon ac- 
tivity in a heterologous species is demonstrated in HeLa but not chick cells. 
Interferon dilution 
1/2 
1/10 
1/20 
1/100 
1/200 
HeLa 
~ber ~erd 
55 
38 
26 
0 
Plaque reduction 
Chick 
per Ce~ 
0 
0 
0 
0 
0 
Mo~e 
p~ce~| 
lO0 
100 
lO0 
96 
85 
nating interferon activity. In this series of experiments we utilized the sensi- 
tivity of interferon to the action of proteolytic enzymes. Again a similar proto- 
col was followed except that in one leukocyte-MEF group trypsin was added 
daily (0.1 to 0.2 ml of a  1 to 200 dilution of trypsin)from day 0, (the time of 
the  addition of vaccinia virus  and leukocytes) while in replicate  leukocyte 
cultures the progression of the infection was followed until control was estab- 
fished and then trypsin was added daily. 
The results of one such experiment are represented in Text-fig. 7. The addi. 
tion of trypsin from day 0 eliminated the protective effect of added leukocytes. 
Similarly when trypsin was  added to  cultures  after the infection had  been 
controlled, progression was again noted and new loci of infection appeared at 
a more rapid rate than in virus-infected leukocyte-MEF cultures which were 
not treated with trypsin. Not only did new plaques appear, but existing plaques 
were observed to be up to three times larger in the trypsin-treated cultures as 
compared to the untreated control cultures. Although in all experiments our 
data were consistent, it should be noted that it was difficult to maintain trypsin- I012  LEUKOCYTES  AND  INTERFERON.  I 
treated cultures satisfactorily to the completion of the experiment, as the cell 
sheets in these bottles peeled much more readily than in other cultures and 
were frequently lost or the plaques became difficult to count. 
The data from this group of experiments are also compatible with the hy- 
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Tzxz-Fm. 7.  Elimination of the protective effect of leukocytes by the addition of trypsin 
(TRYP). No protective effect is demonstrable in the culture to which trypsin and leukocytes 
are added from day 1 (A  A). The addition of trypsin to a leukocyte-MEF culture after 
the protective action of leukocytes is already manifested (A---A) results in the elimination of 
that protective effect. The course of the infection is expressed as plaques per bottle. Each point 
represents the count from 1 bottle. 
pothesis that interferon produced by leukocytes was responsible for the observed 
protective  effect.  The  results,  however,  must  be  interpreted  conservatively 
for the following reasons: (a)  trypsin tends to release infected cells from the 
areas of cell destruction, and thus may enhance the initiation of new foci of 
infection; (b)  trypsin may disperse clumps of virus particles hence increasing 
the possibility of initiation of a  larger number of new plaques; or (c)  trypsin 
could have a  toxic effect on the leukocytes. All of these mechanisms may be LOWELL  A.  GLASGOW  1013 
operative and the observed effect on leukocyte protection could be independent 
of any proteolytic activity on interferon. 
DISCUSSION 
The present study was initiated to investigate the possible contribution of 
leukocytes to host defenses in viral infections. In previous studies we demon- 
strated that vaccinia virus was phagocytosed by, or penetrated, leukocytes 
and induced interferon production in the absence  of virus replication  (24). 
This failure of vaccinia virus multiplication in mouse leukocytes or macrophage 
cultures has been reported by Nishmi and Bernkopf (23) and again more re- 
cently by Nishmi and Niecikowski (25). The presence within a host of a popu- 
lation of cells which takes up virus,  does not permit viral replication,  but re- 
leases  interferon  into  the  surrounding  environment  might  be  expected  to 
enhance the resistance of that host. An in vitro model that would support such 
a  hypothesis was reported by Gresser  and Enders  (33). They demonstrated 
protection of a population of susceptible  cells against Sindbis virus infection 
by the introduction into the culture of cells of a  virus resistant line  which 
responded  to  virus  infection with  interferon production.  It  would  appear 
reasonable,  therefore,  to  postulate  that  leukocytes  or  reticuloendothelial 
system macrophages  might function in a similar fashion either in  ~itro  or it, 
vivo.  In a recent review of a series of studies on the role of the reticuloendo- 
thelial system in viral infections in vivo, Mires  (29) presents evidence that in 
certain virus infections  the virus-phagocytic  cell interaction may be a critical 
determinant in the subsequent course of the disease. The reticuloendothelial 
system has been shown to participate in the clearing of virus particles from the 
circulation during the course of a viremia (29, 34). Interferon production by 
organs  rich  in  reticuloendothelial  cells has  been  demonstrated in  a  rabbit 
system recently reported by Kono and Ho (35) and confirmed in mice in ex- 
periments in our laboratory. Mouse spleen and liver tissue removed within 3 
hours of an experimental viremia and grown in tissue culture were shown to 
produce significant titers of interferon.  That interferon is also produced in vivo 
during these  early phases  of the  host response  to virus infection has  been 
demonstrated by Baron and  Buckler  (36) who  presented  evidence  of peak 
interferon levels occurring in mouse serum within 4 hours following an experi- 
mental viremia in mice. Although it remains to be shown that the reticuloendo- 
thelial system makes a significant contribution to the early interferon response 
and that this interferon in turn is a significant factor in host resistance,  these 
preliminary data support  the developing  concept that interferon, and more 
specifically leukocyte or reticuloendothelial  system-produced interferon, may 
play a role in the host defense against some viral infections. 
A review of the literature concerning vaccinia virus and leukocytes or macro- 
phages reveals  a number of conflicting reports.  The association  or fixation of 1014  LEUKOCYTESAND  INTERFERON.  I 
virus by peripheral leukocytes and peritoneal macrophages has been demon- 
strated repeatedly, but with varied interpretation. Fairbrother  (37)  noted a 
protective effect of leukocytes when combined with immune serum and inocu- 
lated with vaccinia virus intracerebrally. The small number of animals utilized 
in these studies, however, makes evaluation of the work difficult. Douglas and 
Smith  (7)  in addition to the demonstration of virus fixation by leukocytes, 
presented data supporting an antiviral activity of cells from immune animals. 
In contrast, isolation of infectious particles from white blood cells  when no 
free virus was demonstrable in whole blood and the failure of leukocyte cul- 
tures to inactivate vaccinia virus in vitro led Sabin (5)  to conclude that these 
cells were not viricidal for vaccinia. Beard and Rous (19), in an extensive series 
of experiments, demonstrated that phagocytic cells of the reticuloendothelial 
system (Kupffer's cells) did exert a suppressive effect on the pathogenicity of 
vaccinia  virus  when  a  virus-cell  mixture  was  inoculated  intradermally.  In 
similar  experiments,  however,  peripheral  leukocytes and  peritoneal  macro- 
phages failed to alter the normal host response to vaccinia virus infection. In 
opposition to their in  vivo studies,  these authors also presented evidence of 
virus multiplication in the same liver macrophages maintained in tissue cul- 
ture.  In  1941 Florman and Enders  (10)  corroborated  these in  vitro  studies 
utilizing peripheral mononuclear cells  and interpreted their data to indicate 
that phagocytic cells may contribute to the dissemination of virus in vivo. 
It is interesting to note that the studies indicating either failure of leukocytes 
to protect in vivo or of multiplication of virus in vitro have all been carried out 
in rabbit tissue or in rabbits; an animal which is relatively susceptible to vac- 
cinia virus infections. In contrast, the mouse whose leukocytes or macrophages 
appear  resistant  to  vaccinia virus  replication in  tissue  culture  is  relatively 
resistant to infection by this virus in vivo. This proposed correlation is suggested 
by studies of Bang and Warwick (26),  Goodman and Koprowski (27, 28), and 
by work reviewed by Mires (29). Mouse hepatitis virus was observed to multi- 
ply in liver explant macrophages from genetically susceptible mice but not in 
cultures from a  resistant strain (26).  A similar situation obtained in a  group 
B  arbovirus system in which the natural resistance in vivo of a mouse strain 
is reflected in vitro by the failure of its peritoneal macrophages grown in tissue 
culture to support multiplication of virus (27). 
To extrapolate from an in vitro model to man is always hazardous, however 
the question of the possible role of human leukocytes in vaccinia virus infection 
is an important one. Kempe (38) has reported the case of a one-year-old child 
who developed progressive vaccinia which failed to respond to hyperimmune 
gamma globulin. Control of the infection was finally obtained when leukocytes 
from immune donors were injected along the leading edge of the lesion and a 
lymph~ node cell suspension, also from immune donors, was inoculated both 
intramuscularly and intravenously. In view of the data presented that peri- LOWELL A.  GLASGOW  1015 
toneal  leukocytes  and  leukocyte-produced interferon  may  be  a  significant 
factor in limiting the spread of vaccinia virus infection in vitro it is tempting 
to speculate that a similar situation obtained in v/vo; and that interferon pro- 
duction by the donor leukocytes may have contributed to the control of the 
vaccinia virus infection in this child. Furthermore, if we consider the proposed 
correlation of in vitro resistance of leukocytes with in vivo resistance of the host, 
man's degree of susceptibility to vaccinia virus is probably more closely anal- 
ogous to that of the mouse in contrast to the rabbit which readily supports 
vaccinia virus replication in a  number of organ systems in vivo as well as in 
leukocytes and macrophages in ~itro. 
Utilizing the in vitro model described, studies currently in progress in this 
laboratory comparing mouse, rabbit, and human leukocytes suggest that for 
human  leukocytes a  similar protective effect is demonstrable  (39, 40).  It is 
proposed that  while leukocytes may not be the single determining factor in 
host resistance,  in some virus infections interferon production by leukocytes 
may play a  significant role in host defense mechanism and contribute to the 
recovery process. 
SUMMARY 
1.  Investigation of the role of leukocytes in vaccinia virus infection is re- 
ported in an in vitro model, in the absence of an immune response. 
2.  Mouse leukocytes were shown to be capable of inhibiting the progression 
of vaccinia virus infection in primary mouse embryo fibroblast cultures. The 
degree of protection varied from slowing of spread of infection to complete 
control  of  the  infection  with  eventual  elimination  of  detectable  virus  and 
recovery of the culture. 
3.  Interferon production by leukocytes is thought to be an important factor 
in the observed protective effect. 
The author wishes to express  his appreciation  to Mrs. Marcia Norris for her excellent  tech- 
nical assistance, Miss Janet  Cherkasky for preparation of the manuscript, Dr. Herbert R. 
Morgan for his advice and guidance  during the investigation  and preparation of this paper, and 
Dr. Jack Mendelson  for the many challenging  discussions during the course  of the study. 
BIBLIOGRAPHY 
1.  Nicolle, M., and Adil-Bey, Etudes sur le peste bovine, Ann. Inst. Pasteur, 1902,16, 
56. 
2.  Fenner, F., and Woodroofe, G. M., The pathogenesis  of infectious myxomatosis: 
The mechanism  of infection and the immunological response in the European 
rabbit (oryctolagns cuniculus), Brit. J. Exp. Path., 1953, 34, 400. 
3.  TODD, C., Experiments on the virus of fowl plague (I), Brit. ]. Exp. Path., 1928, 
9, 19. 
4.  Smith, W., The distribution of virus and neutralizing antibodies  in the blood and 1016  LEUKOCYTES  AND  INTERFERON.  I 
pathological exudates of rabbits infected with vaccinia, Brit. J. Exp. Path,, 1929, 
10, 93. 
5.  Sabin, A. B., The mechanism of immunity to filterable viruses. III. Role of lenko- 
cytes in immunity to vaccinia, Brit. J. Exp. Path., 1935,16, 158. 
6.  Nelson, E., Hager, H., and Kovacs, E., Intracytoplasmic virus crystal formation 
and other alterations in polymorphonudear leukocytes in mouse polioencepha- 
lifts, Am. J. Path., 1964, 44, 29. 
7.  Douglas, S. R., and Smith, W., Vaccinal immunity in rabbits by means of in vitro 
methods, Brit. J. Exp. Path., 1930, 11, 96. 
8.  Long, P. H., and Olitsky, P. K., The recovery of vaccinia virus after neutraliza- 
tion with immune serum, J. Exp. ]fled., 1930, 51,209. 
9.  Gresser, I., and Chany, C., Isolation of measles virus from the washed leukocytic 
fraction of blood, Proc. Soc. Exp. Biol. and Med., 1963, 118,695. 
10.  Florman, A. L., and Enders, J. F., The effect of homologous antiserum and com- 
plement on the multiplication of vaccinia virus in roller-tube cultures of blood 
mononuclear cells, J. Immunol., 1942, 43, 159. 
11.  Berg, R. B., and Rosenthal, M. S., Propagation of measles virus in suspension of 
human and monkey leukocytes, Proc. Soc. Exp. Biol. and Med., 1961,106, 581. 
12.  Berg, R. B., Multiplication of ECHO 9 virus in suspensions of human leukocytes, 
Proc. Soc. Exp. Biol. and Med., 1961, 108, 742. 
13.  Roberts, J. A.,  Growth of virulent and attenuated ectomelia  virus in cultured 
macrophages from normal and immune mice, Y. Iramunol. 1954, 92,837. 
14.  Ginsberg, H. S., and Blackmon, J. R., Reactions of influenza viruses with guinea 
pig polymorphonuclear leukocytes, I. Virus-cell interactions, Virology, 1956, 2, 
618. 
15.  Hanson, R. J., Kempf, J. E., and Boand, A. V., Jr., Phagocytosis  of influenza 
virus.  II. Its occurrence in normal and immune mice, J. Immunol.,  1957, 79, 
422. 
16.  Boand, A. V., Jr., Kempf, J. E., and Hanson, R. J., Phagocytosis  of influenza 
virus. I. In vitro observations,  I. Immunol., 1957, 79, 416. 
17.  Inglot, A., and Davenport, F. M., Studies on the role of leukocytes in infection 
with influenza virus, J. Immunol., 1962, 88, 55. 
18.  Yoffey, J. M., and Sullivan, E. R., The lymphatic pathway from the nose and 
pharynx. The dissemination  of nasally instilled  vaccinia  virus, J. Exp. Med., 
1939, 69, 133. 
19.  Beard, J. W., and Rous,  P., The fate of vaccinia  virus on cultivation in vitro 
with Kupffer cells (reticuloendothelial  cells), I. Exp. Med.,  1938, 67, 883. 
20.  Smorodintsev,  A.  A.,  Factors  of natural  resistance  and  specific immunity  to 
viruses, Virology, 1957, 8, 299. 
21.  Smorodintsev,  A.  A.,  Basic  mechanisms  of nonspecific resistance  to  viruses  in 
animals and man, Advances Virus Research, 1960, 7, 327. 
22.  Inglot, A., and Davenport, F. M., Studies on the role of leukocytes in infection 
with influenza virus, J. Immunol., 1962, 88, 55. 
23.  Nishmi,  M., and Bernkopf, H., The toxic effect of vaccinia  virus on leukocytes 
in vitro, J. Immunol., 1958, 81, 460. LOWELL  A.  GLASGOW  1017 
24.  Glasgow, L. A., and Habd, K., Interferon production by mouse leukocytes in 
~itro and in vivo, J. Exp. Med., 1963, 117, 149. 
25.  Nishmi, M., and Niecikowski,  tL, Interaction of vaccinia  virus and cells in pri- 
mary and continuous culture, Nature, 1963, 199, 1117. 
26.  Bang, F. B., and Warwick,  A., Mouse macrophages  as host ceils for the mouse 
hepatitis virus and the genetic  basis  of their susceptibility,  Proc. Nat. Acad. 
Sc., 1960, 46, 1065. 
27.  Goodman, G. T., and Koprowski, It., Macrophages as a  cellular  expression of 
inherited natural resistance,  Proc. Nat. Acad. So., 1962, 48, 160. 
28.  Goodman,  G., and Koprowski,  It., Study of the mechanism  of innate resistance 
to virus infection, J. Cellular and Corap. Physiol., 1962, 59, 333. 
29.  Minas, C. A., Aspects of the pathogenesis  of virus diseases, Bact. Rev., 1964, 28, 
30. 
30.  Gresser, I., Production of interferon by suspensions  of human leukocytes, Proc. 
Soc. Exp. Biol. and Med., 1961, 108, 799. 
31.  Glasgow, L. A., and ttabd, K., The role of interferon in vaccinia virus infection 
of mouse embryo tissue culture, J. Exp. Med., 1962, 115, 503. 
32.  Merigan,  T. C., Purified interferons: physical properties and species specificity, 
Science, 1964, 145, 811. 
33.  Gresser,  I., and Enders, J.  F., Alteration of cellular resistance to sindbis  virus 
in mixed  cultures of human  cells attributable  to interferon, Virology, 1962, 
16, 428. 
34.  Bruuner, K. T., Hurez, D., McCluskey, R. T., and Benacerraf, B., Blood clear- 
ance of Pss-labeled  vesicular  stomatitis and newcastle  disease viruses  by the 
reticulocndothelial system in mice, J. Immunol.,  1961, 85, 99. 
35.  Kono, Y., and Ho, M., The role of reticuloendothelial system in interferon forma- 
tion in the rabbit, Virology, in press. 
36.  Baron, S., and Buckler, C., Circulating  interferon in mice after intravenous in- 
jection of virus, Science, 1963, 1#.l, 1061. 
37.  Fairbrother, R. W., The production of immunity to vaccinia virus by mixtures 
of immune serum and virus and the importance of phagocytosis in antivaccinial 
immunity, J. Path. and Bact., 1933, 86, 55. 
38.  Kempe, C. H., Studies  on smallpox and complications  of smallpox vaccination, 
Pediatrics, 1960, 9.6, 175. 
39. Parsons, D. W., and Glasgow, L. A., work in progress. 
40.  Glasgow, L. A., work in progress. 1018  LEUKOCYTES AND INTERFERON. I 
EXPLANATION OF PLATE  81 
FiG. I. Plaque-like focus  of vaccinia virus  infection in primary  MEF cultures, day 
1 to 2.  ×  50. 
FIG. 2.  Progression of the focus of infection in control culture, day 3 to 4.  ×  50. 
FIG. 3.  Ultimate wide-spread vaccinia virus CPE  in unprotected controls, day 5 
to 7.  X  50. 
FIG. 4.  Vaccinia virus CPE in primary MEF culture to which peritoneal leukocytes 
have been added, day 1 to 2.  X  50. 
Fire 5.  Failure of progression of the viral lesion in leukocyte-MEF culture. New cell 
growth in the area of CPE may be noted.  X  50. 
FIG. 6.  In vitro recovery in a  leukocyte-MEF culture with disappearance of viral 
CPE and formation of new healthy cell monolayer. X  50. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 121  PLATE  81 
(Glasgow:  Leukocytes and interferon. I) 